The neurobiology of pain and its modulation - PubMed (original) (raw)
Review
The neurobiology of pain and its modulation
R Dubner et al. Clin J Pain. 1989.
Abstract
Recent research advances indicate that specialized neural pathways are involved in the encoding of pain sensations and that these pathways are sensitive to changes in stimulus features, such as intensity, quality, duration, and location. It has also been established that there are three major families of opioid peptides in the brain: the enkephalins, the dynorphins, and the endorphins. In addition to these opioid peptides, other neurochemicals such as serotonin and norepinephrine play a role in the modulation of signals related to tissue damage. These advances in research are being used to develop improved methods for the control of acute and chronic pain. Nonsteroidal anti-inflammatory drugs suppress noxious signals by reducing the sensitization of peripheral nociceptors. Opioid drugs are administered into the membranes surrounding the spinal cord to provide long-lasting pain relief. Peripherally acting opioid drugs may represent a new functional class of analgesics devoid of the undesirable side effects of centrally acting opioids. Tricyclic antidepressant drugs are used in the treatment of neuropathic pain, based on their effects on noradrenergic and serotoninergic pathways in the central nervous system.
Similar articles
- Opioids in chronic pain.
Przewłocki R, Przewłocka B. Przewłocki R, et al. Eur J Pharmacol. 2001 Oct 19;429(1-3):79-91. doi: 10.1016/s0014-2999(01)01308-5. Eur J Pharmacol. 2001. PMID: 11698029 Review. - [Pain and opioids].
Murányi M, Radák Z. Murányi M, et al. Orv Hetil. 2008 Dec 14;149(50):2363-70. doi: 10.1556/OH.2008.28449. Orv Hetil. 2008. PMID: 19073443 Review. Hungarian. - [Neurophysiologic mechanisms of pain].
Limanskiĭ IuP. Limanskiĭ IuP. Fiziol Zh (1978). 1980 Mar-Apr;26(2):235-44. Fiziol Zh (1978). 1980. PMID: 6153993 Review. Russian. No abstract available. - [Review of current pharmacologic treatment of pain].
Brasseur L. Brasseur L. Drugs. 1997;53 Suppl 2:10-7. doi: 10.2165/00003495-199700532-00005. Drugs. 1997. PMID: 9190320 Review. French. - Opioids and opioid receptors mediating antinociception at various levels of the neuraxis.
Herz A, Millan MJ. Herz A, et al. Physiol Bohemoslov. 1990;39(5):395-401. Physiol Bohemoslov. 1990. PMID: 1965232 Review.
Cited by
- Navigating Preclinical Models and Medications for Peripheral Neuropathy: A Review.
Jali AM, Banji D, Banji OJF, Hurubi KY, Tawhari FY, Alameer AA, Dohal AS, Zanqoti RA. Jali AM, et al. Pharmaceuticals (Basel). 2024 Jul 31;17(8):1010. doi: 10.3390/ph17081010. Pharmaceuticals (Basel). 2024. PMID: 39204115 Free PMC article. Review. - Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress.
Shi Y, Wu W. Shi Y, et al. BMC Med. 2023 Sep 29;21(1):372. doi: 10.1186/s12916-023-03076-2. BMC Med. 2023. PMID: 37775758 Free PMC article. Review. - Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia.
Palmer RH, Periclou A, Banerjee P. Palmer RH, et al. Ther Adv Musculoskelet Dis. 2010 Aug;2(4):201-20. doi: 10.1177/1759720X10372551. Ther Adv Musculoskelet Dis. 2010. PMID: 22870448 Free PMC article. - Milnacipran for the management of fibromyalgia syndrome.
Ormseth MJ, Eyler AE, Hammonds CL, Boomershine CS. Ormseth MJ, et al. J Pain Res. 2010 Mar 1;3:15-24. doi: 10.2147/jpr.s7883. J Pain Res. 2010. PMID: 21197306 Free PMC article. - Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment.
Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Bellato E, et al. Pain Res Treat. 2012;2012:426130. doi: 10.1155/2012/426130. Epub 2012 Nov 4. Pain Res Treat. 2012. PMID: 23213512 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical